Temas
Mostrando ítems 1-5 de 5
-
Anti-VP6 VHH : an experimental treatment for rotavirus A-associated disease
(2016)Species A Rotaviruses (RVA) remain a leading cause of mortality in children under 5 years of age. Current treatment options are limited. We assessed the efficacy of two VP6-specific llama-derived heavy chain antibody ... -
IgY-technology (egg yolk antibodies) in human medicine: a review of patents and clinical trials
(Elsevier, 2020-04)IgY-technology (the production and extraction of specific IgY antibodies from egg yolk) is an innovative method to produce antibodies for therapy and prophylaxis. Advantages of IgY over other antibodies comprise its ... -
Isolation and clinical sample typing of human leptospirosis cases in Argentina
(2016)Leptospira typing is carried out using isolated strains. Because of difficulties in obtaining them, direct identification of infective Leptospira in clinical samples is a high priority.Multilocus sequence typing (MLST) ... -
Prevención y tratamiento de Rotavirus A mediante nanoanticuerpos VHH anti-VP6
(Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, 2017-06)La diarrea asociada a Rotavirus A (RVA) representa una de las principales causas de mortalidad infantil a nivel mundial. Si bien la vacunación masiva contra RVA ha logrado disminuir significativamente las muertes causadas ... -
Relevancia clínica, diversidad y variabilidad genética de distintas especies del género Mycobacterium
(2017)Introducción: El término micobacterias no tuberculosas (MNT) incluye distintas especies ambientales capaces de enfermar humanosy/o animales incluso mediante una probable transmisión zoonótica Objetivos. Determinar: la ...